6-31884444-G-T

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_006709.5(EHMT2):​c.2719C>A​(p.Leu907Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000248 in 1,612,806 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00025 ( 0 hom. )

Consequence

EHMT2
NM_006709.5 missense

Scores

1
1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.64
Variant links:
Genes affected
EHMT2 (HGNC:14129): (euchromatic histone lysine methyltransferase 2) This gene encodes a methyltransferase that methylates lysine residues of histone H3. Methylation of H3 at lysine 9 by this protein results in recruitment of additional epigenetic regulators and repression of transcription. This gene was initially thought to be two different genes, NG36 and G9a, adjacent to each other in the HLA locus. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.11542338).
BS2
High AC in GnomAd4 at 31 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
EHMT2NM_006709.5 linkuse as main transcriptc.2719C>A p.Leu907Ile missense_variant 21/28 ENST00000375537.9 NP_006700.3 Q96KQ7-1A0A024RCN9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
EHMT2ENST00000375537.9 linkuse as main transcriptc.2719C>A p.Leu907Ile missense_variant 21/281 NM_006709.5 ENSP00000364687.4 Q96KQ7-1

Frequencies

GnomAD3 genomes
AF:
0.000204
AC:
31
AN:
152174
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000397
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000260
AC:
64
AN:
246362
Hom.:
0
AF XY:
0.000238
AC XY:
32
AN XY:
134302
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000261
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000988
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000452
Gnomad OTH exome
AF:
0.000329
GnomAD4 exome
AF:
0.000253
AC:
369
AN:
1460632
Hom.:
0
Cov.:
32
AF XY:
0.000253
AC XY:
184
AN XY:
726642
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000358
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000696
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000299
Gnomad4 OTH exome
AF:
0.000232
GnomAD4 genome
AF:
0.000204
AC:
31
AN:
152174
Hom.:
0
Cov.:
32
AF XY:
0.000242
AC XY:
18
AN XY:
74340
show subpopulations
Gnomad4 AFR
AF:
0.0000483
Gnomad4 AMR
AF:
0.0000655
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000397
Gnomad4 OTH
AF:
0.000478
Alfa
AF:
0.000306
Hom.:
4
Bravo
AF:
0.000230
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000738
AC:
4
ExAC
AF:
0.000296
AC:
35
EpiCase
AF:
0.000491
EpiControl
AF:
0.000533

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 05, 2024The c.2719C>A (p.L907I) alteration is located in exon 21 (coding exon 21) of the EHMT2 gene. This alteration results from a C to A substitution at nucleotide position 2719, causing the leucine (L) at amino acid position 907 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
23
DANN
Benign
0.97
DEOGEN2
Benign
0.062
.;.;.;T
Eigen
Benign
-0.15
Eigen_PC
Benign
-0.012
FATHMM_MKL
Uncertain
0.96
D
M_CAP
Benign
0.052
D
MetaRNN
Benign
0.12
T;T;T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
0.99
.;.;.;L
PrimateAI
Pathogenic
0.80
T
PROVEAN
Benign
-0.62
N;N;N;N
REVEL
Benign
0.10
Sift
Benign
0.17
T;T;T;T
Sift4G
Benign
0.29
T;T;T;T
Polyphen
0.0070, 0.0030, 0.0010
.;B;B;B
Vest4
0.33
MVP
0.67
MPC
1.0
ClinPred
0.036
T
GERP RS
5.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.065
gMVP
0.49

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs145277546; hg19: chr6-31852221; API